SEVEN EIGHT CAPITAL, LP - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 173 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEVEN EIGHT CAPITAL, LP ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$80,792
-47.8%
10,398
-34.9%
0.01%
-65.4%
Q2 2023$154,715
+15.5%
15,983
-10.6%
0.03%
-3.7%
Q3 2022$134,000
-62.4%
17,881
-49.5%
0.03%
-81.1%
Q2 2022$356,000
-74.6%
35,408
-68.7%
0.14%
-23.5%
Q1 2022$1,403,000
-78.1%
113,303
-60.8%
0.19%
-69.6%
Q3 2021$6,392,000
+994.5%
288,840
+540.7%
0.62%
+651.2%
Q2 2021$584,000
+8.8%
45,080
+23.7%
0.08%
-29.3%
Q3 2020$537,000
+52.1%
36,434
+49.9%
0.12%
+27.5%
Q1 2020$353,00024,3000.09%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders